Nova Patents
IL223181B

(r)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin 1-yl)prop-2-en-1-one for use as a medicament for the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

127 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
35113010United States of AmericaP
35165510United States of AmericaP
35176210United States of AmericaP
35179310United States of AmericaP
41976410United States of AmericaP
201161472138United States of AmericaP
2011039190United States of AmericaW

Members127

Family members, oldest first
DocumentOfficeKind
CA2800913A1CanadaA1
CA3007787A1CanadaA1
CA3007788A1CanadaA1
CA3022256A1CanadaA1
CA3113343A1CanadaA1
CA3154024A1CanadaA1
CA3240281A1CanadaA1
WO2011153514A2World Intellectual Property Organization (WIPO)A2
US2012071497A1United States of AmericaA1
WO2011153514A9World Intellectual Property Organization (WIPO)A9
US2012087915A1United States of AmericaA1
US2012100138A1United States of AmericaA1
US2012183535A1United States of AmericaA1
AU2011261185A1AustraliaA1
SG186077A1SingaporeA1
IL223181A0IsraelA0
IL223181D0IsraelD0
PH12012502356A1PhilippinesA1
MX2012014049AMexicoA
CL2012003381A1ChileA1
EP2575818A2European Patent Office (EPO)A2
CN103153311AChinaA
JP2013527249AJapanA
US2013195852A1United States of AmericaA1
KR20130086957ARepublic of KoreaA
US2013202611A1United States of AmericaA1
EA201270793A2Eurasian Patent Organization (EAPO)A2
US2013273030A1United States of AmericaA1
EP2575818A4European Patent Office (EPO)A4
US2013310402A1United States of AmericaA1
ZA201209381BSouth AfricaB
US8754090B2United States of AmericaB2
US2014194446A1United States of AmericaA1
US2015031710A1United States of AmericaA1
US2015031711A1United States of AmericaA1
UA107707C2UkraineC2
NZ604040ANew ZealandA
US8999999B2United States of AmericaB2
US9125889B2United States of AmericaB2
KR101580714B1Republic of KoreaB1
JP5841998B2JapanB2
AU2015275321A1AustraliaA1
JP2016065078AJapanA
NZ702485ANew ZealandA
US2016175312A1United States of AmericaA1
US2016243033A1United States of AmericaA1
MX342405BMexicoB
US2016324859A1United States of AmericaA1
JP6057309B2JapanB2
US2017035762A1United States of AmericaA1
JP2017039767AJapanA
BR112012030625A2BrazilA2
US9801881B2United States of AmericaB2
US9801883B2United States of AmericaB2
US9814721B2United States of AmericaB2
NZ717373ANew ZealandA
US2018015091A1United States of AmericaA1
US2018036313A1United States of AmericaA1
PH12016501206A1PhilippinesA1
PH12016501206B1PhilippinesB1
AU2015275321B2AustraliaB2
CN107898791AChinaA
US10004745B2United States of AmericaB2
US10004746B2United States of AmericaB2
AU2018204179A1AustraliaA1
US10016435B2United States of AmericaB2
JP6376416B2JapanB2
US2018256581A1United States of AmericaA1
EA201890869A2Eurasian Patent Organization (EAPO)A2
US2018280395A1United States of AmericaA1
US2018311153A1United States of AmericaA1
SG10201809111XASingaporeA
JP2018197238AJapanA
EA201270793A8Eurasian Patent Organization (EAPO)A8
EA031737B1Eurasian Patent Organization (EAPO)B1
EA201890869A3Eurasian Patent Organization (EAPO)A3
CA2800913CCanadaC
JP6580760B2JapanB2
NZ736048ANew ZealandA
US10478439B2United States of AmericaB2
US2019358234A1United States of AmericaA1
CA3007787CCanadaC
CA3007788CCanadaC
JP2020063231AJapanA
AU2020202752A1AustraliaA1
US10653696B2United States of AmericaB2
US2020163968A1United States of AmericaA1
US2020246259A1United States of AmericaA1
US10751342B2United States of AmericaB2
NZ753024ANew ZealandA
IL275459AIsraelA
IL223181AIsraelA
IL223181BThis recordIsraelB
MX2020004438AMexicoA
CA3022256CCanadaC
NZ755485ANew ZealandA
US2021169885A1United States of AmericaA1
JP2021155426AJapanA
MX2020004501AMexicoA
PH12021550758A1PhilippinesA1
Showing 100 of 127